ImmunoPrecise Appoints Kristin Taylor as Chief Financial Officer

Stock Information for ImmunoPrecise Antibodies Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ImmunoPrecise Antibodies Ltd.

ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus
ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments
ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025
IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 on September 16, 2024
ImmunoPrecise Antibodies to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York
ImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid Requirements
ImmunoPrecise Antibodies Successfully Engineers in silico Antibodies to Elusive Tumor Protein Using Its Patented LENSai Technology
ImmunoPrecise Antibodies (IPA) Reports Financial Results and Business Updates for Fourth Quarter and Full Fiscal Year 2024

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.